SCHEMBL718383

SCHEMBL718383

C=Cc1c(N)nc(-c2ccc(F)cc2)nc1C(=O)OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
CASP3 P42574 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
IKBKB O14920 1/20 0.40
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
KDM4E B2RXH2 3/20 0.39
PKM P14618 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
ALDH1A1 P00352 1/20 0.39
DHPS P49366 2/20 0.39
ADORA3 P0DMS8 3/20 0.38
ADORA2A P29274 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16035755 0.90 KDM4E (0.40) LMNASMN1; SMN2NPC1RAB9ACA12
SCHEMBL719539 0.90 CA12 (0.47) LMNASMN1; SMN2NPC1RAB9ACA12
SCHEMBL721162 0.89 KDM4E (0.51) LMNASMN1; SMN2NPC1RAB9ACASP3
SCHEMBL720191 0.89 KDM4E (0.41) SMN1; SMN2NPC1RAB9ACA12CA1
SCHEMBL719542 0.88 ERN1 (0.39) SMN1; SMN2CA12CA1CA2CA9
SCHEMBL719484 0.88 RAB9A (0.41) SMN1; SMN2NPC1RAB9ACA12CA1
SCHEMBL16036947 0.88 KDM4E (0.39) SMN1; SMN2NPC1RAB9ACA12CA1
SCHEMBL719375 0.87 ADORA3 (0.41) SMN1; SMN2IKBKBKDM4EPKML3MBTL1
SCHEMBL717010 0.86 ADORA3 (0.46) KDM4EPKML3MBTL1ADORA3FPR2
SCHEMBL716684 0.86 KDM4E (0.36) LMNASMN1; SMN2RAB9AKDM4EPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120053053-A1 PYRIMIDINE DERIVATIVES AND THEIR USE AS HERBICIDES SYNGENTA CROP PROTECTION, LLC (US) 2012-03-01 US disclosed
US-20120053053-A1 PYRIMIDINE DERIVATIVES AND THEIR USE AS HERBICIDES SYNGENTA CROP PROTECTION, LLC (US) 2012-03-01 US disclosed
US-20120053053-A1 PYRIMIDINE DERIVATIVES AND THEIR USE AS HERBICIDES SYNGENTA CROP PROTECTION, LLC (US) 2012-03-01 US disclosed
WO-2010092339-A1 PYRIMIDINE DERIVATIVES AND THEIR USE AS HERBICIDES SYNGENTA LIMITED (GB) 2010-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120053053-A1 PYRIMIDINE DERIVATIVES AND THEIR USE AS HERBICIDES DPYD, DHODH, TYMP LMNA 4613/4885SMN1; SMN2 2864/4885NPC1 4477/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.